TAT-NSF700 Fusion Peptide – 1 mg

Overview

The TAT-NSF700 Fusion Peptide is a powerful tool designed for research focused on thrombin-induced exocytosis of endothelial cells. This peptide combines the 11-amino acid HIV transactivating regulatory protein (TAT) domain with a 22-amino acid N-Ethyl-maleimide-sensitive factor (NSF) domain, creating a highly effective inhibitor. Scientists and researchers will appreciate its capability to inhibit exocytosis in a dose-responsive manner, making it an essential asset for various experimental applications.

Key Features

• Dual functionality as a TAT domain fused with an NSF domain
• Effectively inhibits thrombin-induced exocytosis of endothelial cells
• Utilizes a dose-responsive mechanism for precise research outcomes
• Cell permeable for easier application in research settings
• Compatible with various assays and experimental protocols

Specifications

FAQ

What is the mechanism of action for TAT-NSF700?

The TAT-NSF700 Fusion Peptide inhibits thrombin-induced exocytosis by targeting the NSF pathway, effectively preventing the release of cellular contents in response to thrombin.

Can TAT-NSF700 be used in different types of assays?

Yes, this peptide is versatile and can be utilized in various experimental setups, including assays focused on cellular signaling and exocytosis.

How should I store TAT-NSF700 Fusion Peptide?

It is recommended to store the TAT-NSF700 Fusion Peptide at -20°C to maintain stability and activity. Always follow best practices for peptide storage.

For those exploring the world of peptides, our TAT-NSF700 Fusion Peptide is a worthy addition to your toolkit. With its proven effectiveness, why not shop our peptide selection today and discover how it can enhance your research? Don’t miss out on the chance to integrate this powerful peptide into your studies.

Related Products

• PKG Substrate [RKRSRAE], Glasstide
• Autocamtide-2 [KKALRRQETVDAL]
• CREBtide [KRREILSRRPSYR], 5-FAM labeled